CLINICAL_TRIALS
trial_result
· 2022-05-04
Clinical Trial Update: A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation [NA]
Summary
A completed safety and feasibility study evaluating the FARAPULSE Endocardial Ablation System for paroxysmal atrial fibrillation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2022-05-04